RETRACTION: Transfer of microRNA-221 from mesenchymal stem cell-derived extracellular vesicles inhibits atherosclerotic plaque formation (Retraction of Vol 226, Pg 83, 2020)

被引:0
|
作者
Guo, Ziyuan [1 ]
Zhao, Zhuo [1 ]
Yang, Chuang [1 ]
Song, Chunli [1 ]
机构
[1] Second Hosp Jilin Univ, Dept Cardiovasc Internal Med, Changchun 130041, Peoples R China
关键词
D O I
10.1016/j.trsl.2024.03.010
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:97 / 97
页数:1
相关论文
共 35 条
  • [31] MicroRNA-15a Carried by Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibits the Immune Evasion of Colorectal Cancer Cells by Regulating the KDM4B/HOXC4/PD-L1 Axis
    Liu, Lei
    Yu, Ting
    Jin, Yanping
    Mai, Wei
    Zhou, Jing
    Zhao, Chunbo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [32] RETRACTED: MicroRNA-15b shuttled by bone marrow mesenchymal stem cell-derived extracellular vesicles binds to WWP1 and promotes osteogenic differentiation (Retracted article. See vol. 24, 2022)
    Li, Yanhong
    Wang, Jing
    Ma, Yanchao
    Du, Wenjia
    Feng, Haijun
    Feng, Kai
    Li, Guangjie
    Wang, Shuanke
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [33] RETRACTED: Bone marrow mesenchymal stem cells-derived extracellular vesicles carrying microRNA-221-3p protect against ischemic stroke via ATF3 (Retracted article. See vol. 189, pg. 153, 2022)
    Ai, Zhibing
    Cheng, Chaohui
    Zhou, Lan
    Yin, Songhe
    Wang, Lei
    Liu, Yong
    BRAIN RESEARCH BULLETIN, 2021, 172 : 220 - 228
  • [34] Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19: A Randomized, Placebo-Controlled Dosing Clinical Trial (vol 164, pg 1444, 2023)
    Lightner, Amy L.
    Sengupta, Vikram
    Qian, Sascha
    Ransom, John T.
    Suzuki, Sam
    Park, David J.
    Melson, Timothy, I
    Williams, Brian P.
    Walsh, James J.
    Awili, Mustafa
    CHEST, 2024, 166 (01) : 240 - 240
  • [35] RETRACTION: Extracellular vesicle-encapsulated microRNA-425-derived from drug-resistant cells promotes non-small-cell lung cancer progression through DAPK1-medicated PI3K/AKT pathway (Retraction of Vol 236, Pg 3808, 2021)
    Guo, Zhihua
    Ye, Huangyang
    Zheng, Xiaobin
    Yin, Weiqiang
    He, Jianxing
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022,